NEW YORK, Nov. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Therapeutic Apheresis - A US Market Review

http://www.reportlinker.com/p0164235/Therapeutic-Apheresis---A-US-Market-Review.html

Although therapeutic apheresis is a potential market, soaring treatment costs and lack of awareness debilitate its growth. However, with increasing alliances and agreements, research for new procedures and more sophisticated applications underway, apheresis technology is likely to have major market opportunities for supplies, services and equipment. Reimbursement policies of both government and private insurance companies play a major role in the increase of therapeutic application in several diseases. Emerging applications of therapeutic apheresis in Autoimmune Diseases, Refractory Chronic GvHD, Lupus Erythematosus, Hyperlipidemia, Atherosclerosis and Renal Diseases are forecast to bolster volumes of growth. The pediatric segment provides a potential opportunity to expand the therapeutic apheresis market.

These and other market data and trends are presented in "Therapeutic Apheresis: US Market Review" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

THERAPEUTIC APHERESIS BMR-1035

Contents

1. METHODOLOGY 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Quantitative Techniques & Reporting Level 3

2. MARKET ANALYSIS 3

A Promising Outlook 4

3. MARKET TRENDS 5

Apheresis Process Leads to Rise in Platelet Donors 5

Therapeutic Apheresis Devices - A Perplexing Market 5

Plateletpheresis: The Treatment of Choice for Patients 5

Photopheresis Market Growing at a High Rate 6

Vendors' Attitude Hampers Growth Prospects of Therapeutic

Apheresis 6

Developing New Applications for Therapeutic Apheresis is the

Need of the Hour 7

CFA - An Effective Way to Pull Up Cold Hemagglutinin Disease 7

4. COMPETITIVE SCENARIO 8

Overview 8

Technology: The Only Key for Success 8

CaridianBCT: The World Leader 9

Market Share Trends in the Recent Past 9

By Procedures (Revenues) 9

By Procedures (Number of Procedures) 10

By Neurology Disorders (Revenues) 10

By Neurology Disorders (Number of Procedures) 11

By Hematology and Oncology Disorders (Revenues) 11

By Hematology and Oncology (Number of Procedures) 12

5. MARKET OVERVIEW & OUTLOOK 12

Market Drivers 13

New Reimbursement Policies Create Growth Opportunities for

Therapeutic Apheresis 13

Increased Industry Consolidation Drives Research 13

Development of New Technology 14

Research Unveils Novel Applications 14

Market Restraints 14

Lack of Awareness Restrains Growth 14

Therapeutic Apheresis Costs Still a Concern 14

Market Challenges 15

Development of Inexpensive Apheresis Therapy 15

Scarcity of Qualified Donors 15

Pediatry: An Untapped Opportunity 15

6. REGULATORY ENVIRONMENT 16

7. PRODUCT FACTS 17

Plasmapheresis 17

Immunoadsorption 17

Erythrocytapheresis 17

Plateletpheresis 17

Leukapheresis 17

Photopheresis 17

Lipidpheresis 18

8. PRODUCT TRENDS AND ISSUES 19

Therapeutic Plasmapheresis with Fresh Frozen Plasma (FFP)

Replacement 19

Risks Associated with Therapeutic Apheresis 20

Categories of Indications for Therapeutic Apheresis 20

Plasma Exchange and Plasmapheresis: The Difference 21

Applications of Plasma Exchange 21

Chronic Diseases 21

Acute Self-Limited Disease 21

Emerging Applications 22

9. CORPORATE DEVELOPMENTS 22

Gambro to Change Name to CaridianBCT 22

Therakos Obtains CE Mark in Europe 22

Baxter Divests Transfusion Therapies Business 23

SCSG Gets Hold of Fresenius Medical Care Extracorporeal Alliance 23

Rheologics Technologies Takes Over Cardiodyne Electronics 23

Biotest Obtains Business Unit of Nabi BioPharmaceuticals 23

Gambro BCT Receives FDA Clearance for Spectra Optia System 23

MedaSorb Receives Rights for Blood Processing 24

10. MAJOR PLAYERS 24

Baxter Healthcare Corporation 24

CaridianBCT, Inc. 24

Fenwal, Inc. 25

Fresenius Medical Care North America (FMCNA) 25

Haemonetics Corporation 25

HemaCare Corporation 26

Hospital Clinical Services Group, Inc. (HCSG) 26

Therakos, Inc 26

11. MARKET ANALYTICS 27

EXHIBITS

Table 1: Percentage Breakdown of Leading Players in the US

Market for Therapeutic Apheresis - 2005

Table 2: Percentage Breakdown of Leading Players in the US

Market for Therapeutic Apheresis - 2005

Table 3: Percentage Breakdown of Leading Players in the US

Market for Therapeutic Apheresis in Neurological Disorders -

2005

Table 4: Percentage Breakdown of Leading Players in the US

Market for Therapeutic Apheresis in Neurological Disorders -

2005

Table 5: Percentage Breakdown of Leading Players in the US

Market for Therapeutic Apheresis in Hematology and Oncology

Disorders - 2005

Table 6: Percentage Breakdown of Leading Players in the US

Market for Therapeutic Apheresis in Hematology and Oncology

Disorders - 2005

Table 7: Therapeutic Apheresis Market by Procedure in the US:

2007-2015 (Sales in US$ Thousand)

Table 8: Percentage Breakdown of Therapeutic Apheresis Market

by Procedure in the US for the Years 2008 & 2012

Table 9: Therapeutic Apheresis Market by End Use in the US:

2007-2015 (Sales in US$ Thousand)

Table 10: Percentage Breakdown of Therapeutic Apheresis Market

by End Use in the US for the Years 2008 & 2012

COMPANIES PROFILED

To order this report:

Therapy Industry: Therapeutic Apheresis - A US Market Review

More Market Research Report

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

Back to top

RELATED LINKS
http://www.reportlinker.com